Health & Wellness

FDA announced the approval of a new drug specifically formulated to treat postpartum depression (PPD)

FDA announced the approval of a new drug specifically formulated to treat postpartum depression (PPD)

The FDA announced the approval of a new drug, Zulresso, that is specifically formulated to treat postpartum depression (PPD). It is administered via IV infusion over 60 hours and requires hospital admission. While there has been some negativity surrounding the administration and side effects of this particular drug, the announcement is about something more than…